Actively Recruiting
Optimising Breathing Support at Extubation in Very Preterm Infants: A Clinical Study
Led by Murdoch Childrens Research Institute · Updated on 2026-05-07
134
Participants Needed
2
Research Sites
99 weeks
Total Duration
On this page
Sponsors
M
Murdoch Childrens Research Institute
Lead Sponsor
W
Western Health, Australia
Collaborating Sponsor
AI-Summary
What this Trial Is About
Many babies born very preterm (\<32 weeks of pregnancy) require support to breathe from a breathing machine (mechanical ventilator) via a breathing tube. Although this keeps babies alive, it can damage their lungs. To reduce this damage, doctors and nurses try to change babies to gentler breathing support that does not require a breathing tube. This is usually done using a method called nasal continuous positive airway pressure (nCPAP) that uses a nosepiece to deliver breaths. This process of removing the breathing tube is called "extubation". Many babies will need the breathing tube put back in after extubation (for various reasons) and this is independently associated with poorer outcomes. This research study aims to compare two ways of performing extubation - both of which are already used regularly by doctors and nurses. The "standard extubation" approach involves taking a baby's breathing tube out first, then applying the nosepiece and starting nCPAP. The more recent approach, called "prePAP", involves applying the nosepiece and starting nCPAP before taking the breathing tube out. Previous research suggests that a prePAP approach may provide better support for babies during extubation. However, larger studies are required before this approach is more commonly used. This study is investigating whether extubating the baby with prePAP is better than extubating the baby without prePAP. The main question it aims to answer is: Does initiating nCPAP before extubation in very preterm babies reduce the fall in their oxygen levels post-extubation?
CONDITIONS
Official Title
Optimising Breathing Support at Extubation in Very Preterm Infants: A Clinical Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- The infant is admitted to a participating neonatal intensive care unit (NICU)
- The infant was born between 22 weeks 0 days and 29 weeks 6 days gestational age
- The infant has been on invasive mechanical ventilation for at least 4 hours
- The infant is being electively extubated for the first time from invasive ventilation to nasal continuous positive airway pressure (nCPAP)
- The infant is clinically stable as determined by the clinical and research team
- Parent(s) or legal guardian(s) provide informed consent
You will not qualify if you...
- The infant was born before 22 weeks or after 30 weeks gestational age
- The infant has major congenital anomalies affecting the heart, lungs, or digestive system, or has a known genetic syndrome affecting respiratory outcomes
- The infant has severe lung underdevelopment caused by low amniotic fluid before 22 weeks, expected to cause respiratory failure
- The infant is receiving invasive ventilation through a nasotracheal tube
- The infant is planned for extubation to any support other than nCPAP or no respiratory support
- Parent(s) refuse informed consent or no guardian is available to provide consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
The Royal Women's Hospital
Melbourne, Victoria, Australia, 3050
Not Yet Recruiting
2
Joan Kirner Women's and Children's Hospital
Saint Albans, Victoria, Australia, 3021
Actively Recruiting
Research Team
G
Georgia S Stephen, BBmedSc BBiomedSc(Hons)
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here